Company to host a virtual webinar on PRMT5 data and the synthetic lethality pipeline, including WRN and novel target discovery, today Monday, October 16 at 9.30 am CEST Presentations include updated data from the lead preclinical program on MTA-cooperative PRMT5 inhibitors Preclinical…